1 Min Read
Oct 23 (Reuters) - TRANSGENE SA:
* TG1050 IS WELL TOLERATED AND INDUCES A STRONG SPECIFIC IMMUNE RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS B Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.